Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  70,336 results for ""Benzimidazoles""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Design, Synthesis and Biological Activity of Novel Methoxy- and Hydroxy-Substituted N -Benzimidazole-Derived Carboxamides.

  • Authors : Beč A; Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Marulićev Trg 19, 10000 Zagreb, Croatia.; Zlatić K

Subjects: Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/chemistry ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/pharmacology ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/chemical synthesis

  • Source: Molecules (Basel, Switzerland) [Molecules] 2024 May 04; Vol. 29 (9). Date of Electronic Publication: 2024 May 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

Read More Add to Saved list
×
Academic Journal

High affinity and low PARP-trapping benzimidazole derivatives as a potential warhead for PARP1 degraders.

  • Authors : Peng X; Institute of Pharmacy and Pharmacology, Cooperative Innovation Center for Molecular Target New Drug Study, College of Pharmacy, Hengyang Medical School, University of South China, Hengyang, China.; Li Y

Subjects: Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/chemistry ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/pharmacology ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/chemical synthesis

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 May 05; Vol. 271, pp. 116405. Date of Electronic Publication: 2024 Apr 25.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.

  • Authors : Li SS; Department of Medicinal and Organic Chemistry, College of Pharmacy, Xinjiang Medical University, Urumqi, 830011, China.; Chen JJ

Subjects: Drug Design* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemical synthesis

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 May 05; Vol. 271, pp. 116425. Date of Electronic Publication: 2024 Apr 16.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Development of benzimidazole-based compounds as novel capsid assembly modulators for the treatment of HBV infection.

  • Authors : Du K; Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China; Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.

Subjects: Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/chemistry ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/pharmacology ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/chemical synthesis

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 May 05; Vol. 271, pp. 116402. Date of Electronic Publication: 2024 Apr 16.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial).

Subjects: Sofosbuvir*/Sofosbuvir*/Sofosbuvir*/therapeutic use ; Sofosbuvir*/Sofosbuvir*/Sofosbuvir*/adverse effects ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use

  • Source: Scientific reports [Sci Rep] 2024 May 03; Vol. 14 (1), pp. 10244. Date of Electronic Publication: 2024 May 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and safety of selumetinib in patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: a systematic review and meta-analysis.

  • Authors : Han Y; Department of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, Henan, China.; Li B

Subjects: Neurofibroma, Plexiform*/Neurofibroma, Plexiform*/Neurofibroma, Plexiform*/drug therapy ; Neurofibromatosis 1*/Neurofibromatosis 1*/Neurofibromatosis 1*/drug therapy ; Neurofibromatosis 1*/Neurofibromatosis 1*/Neurofibromatosis 1*/complications

  • Source: Journal of neurology [J Neurol] 2024 May; Vol. 271 (5), pp. 2379-2389. Date of Electronic Publication: 2024 Mar 19.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Azilsartan prevents muscle loss and fast- to slow-twitch muscle fiber shift in natural ageing sarcopenic rats.

  • Authors : Prajapati P; Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226025, India.; Kumar A

Subjects: Sarcopenia*/Sarcopenia*/Sarcopenia*/prevention & control ; Sarcopenia*/Sarcopenia*/Sarcopenia*/metabolism ; Sarcopenia*/Sarcopenia*/Sarcopenia*/drug therapy

  • Source: Canadian journal of physiology and pharmacology [Can J Physiol Pharmacol] 2024 May 01; Vol. 102 (5), pp. 342-360. Date of Electronic Publication: 2023 Dec 20.Publisher: Canadian Science Publishing Country of Publication: Canada NLM ID: 0372712 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

The new preservative-free ophthalmic formulation of bilastine 0.6% preserves the ocular surface epithelial integrity in a comparative in vitro study.

  • Authors : Arana E; Research, Development and Innovation Department (R&D+I Department), Faes Farma, Av. Autonomía 10, 48940, Leioa, Bizkaia, Spain.; Department of Cell Biology and Histology, School of Medicine and Nursing, University of the Basque Country, Leioa, Spain.

Subjects: Ophthalmic Solutions*/Ophthalmic Solutions*/Ophthalmic Solutions*/pharmacology ; Preservatives, Pharmaceutical*/Preservatives, Pharmaceutical*/Preservatives, Pharmaceutical*/pharmacology ; Cell Survival*/Cell Survival*/Cell Survival*/drug effects

  • Source: Scientific reports [Sci Rep] 2024 Apr 26; Vol. 14 (1), pp. 9598. Date of Electronic Publication: 2024 Apr 26.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CandeSpartan Study: Candesartan Spanish Response-prediction and Tolerability study in migraine.

  • Authors : García-Azorín D; Department of Medicine, Faculty of Medicine, Universidad de Valladolid, Valladolid, Spain.; Headache Unit, Department of Neurology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.

Subjects: Migraine Disorders*/Migraine Disorders*/Migraine Disorders*/drug therapy ; Biphenyl Compounds* ; Benzimidazoles*/Benzimidazoles*/Benzimidazoles*/therapeutic use

  • Source: Cephalalgia : an international journal of headache [Cephalalgia] 2024 Apr; Vol. 44 (4), pp. 3331024241248833.Publisher: Country of Publication: England NLM ID: 8200710 Publication Model: Print Cited Medium: Internet ISSN: 1468-2982 (Electronic)

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cost-effectiveness of maribavir versus conventional antiviral therapies for post-transplant refractory cytomegalovirus infection with or without genotypic resistance: A US perspective.

  • Authors : Schultz BG; Takeda Pharmaceuticals U.S.A., Inc., Lexington, Massachusetts, USA.; Kotton CN

Subjects: Cost-Benefit Analysis* ; Cytomegalovirus Infections*/Cytomegalovirus Infections*/Cytomegalovirus Infections*/drug therapy ; Cytomegalovirus Infections*/Cytomegalovirus Infections*/Cytomegalovirus Infections*/economics

  • Source: Journal of medical virology [J Med Virol] 2024 Apr; Vol. 96 (4), pp. e29609.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071

Record details

Read More Add to Saved list
×
  • 1-10 of  70,336 results for ""Benzimidazoles""